← Leaderboards
Robert H. Bartlett
University Of Michigan At Ann Arbor
$24,314,191
Attributed
$28,651,396
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2005–23$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$28,651,396 · 12
By mechanism
R01$25,213,978 · 7
R42$1,675,558 · 1
R21$835,768 · 2
R34$697,500 · 1
R41$228,592 · 1
Top collaborators
- Mark E Meyerhoff6 shared
- Robert W Neumar6 shared
- Glenn Martin3 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Elizabeth Joy Brisbois$4,815,119
- Mark E Meyerhoff$16,191,724
- Alvaro Rojas-Pena$5,755,664
- Ronald Bruce Hirschl$6,480,439
- Steven P. Schwendeman$6,555,011
Others in their field
Top investigators on “Nitric Oxide”
- Solomon H Snyder · Johns Hopkins University$33,003,131
- Jay Louis Zweier · Ohio State University$27,671,715
- Stuart A Lipton · Burnham Institute For Medical Research$26,301,120
- Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru$24,661,240
- Jonathan S. Stamler · Case Western Reserve University$24,571,968
- William C. Sessa · Yale University$21,022,028
Research focus
Nitric OxideDevicesThrombosisLaboratoriesClinical TrialsLungSurfaceSheepAnimal ModelTechnologyGrantBloodPreventExtracorporeal CirculationChronicClinical ApplicationLung TransplantationDesignLifeGasesBlood CirculationAnimalsAnticoagulationCoagulation Process
Grant awards (50)
Research Supplement to Promote Diversity Supplement for the ECMO without Anticoagulation$43,232
R01 · FY2023 · HL · contact PI
Low Cost Electrochemical Gas Phase Nitric Oxide Generator for Biomedical Applications$865,106
R42 · FY2022 · HL
Prolonged Normothermic Ex vivo Heart Perfusion (NEVHP)$776,002
R01 · FY2022 · HL · contact PI
ECMO without Anticoagulation$764,547
R01 · FY2022 · HL · contact PI
ECMO without Anticoagulation$747,387
R01 · FY2021 · HL · contact PI
Low Cost Electrochemical Gas Phase Nitric Oxide Generator for Biomedical Applications$602,645
R42 · FY2021 · HL
ECPR After Prolonged Cardiac Arrest: Targeting Mechanisms of the No-Reflow$751,384
R01 · FY2020 · HL
ECPR After Prolonged Cardiac Arrest: Targeting Mechanisms of the No-Reflow$756,708
R01 · FY2019 · HL
The Cause of Systemic Inflammatory Response during Cardiopulmonary Bypass and Prevention by Nitric Oxide$674,320
R01 · FY2019 · HL · contact PI
Low Cost Electrochemical Gas Phase Nitric Oxide Generator for Biomedical Applications$207,807
R42 · FY2019 · HL
ECPR After Prolonged Cardiac Arrest: Targeting Mechanisms of the No-Reflow$784,250
R01 · FY2018 · HL
Bactericidal, Nonthrombogenic Intravascular Catheters$697,474
R01 · FY2018 · HL · contact PI
ECPR After Prolonged Cardiac Arrest: Targeting Mechanisms of the No-Reflow$774,905
R01 · FY2017 · HL
Bactericidal, Nonthrombogenic Intravascular Catheters$717,819
R01 · FY2017 · HL · contact PI
Extracorporeal CPR for Refractory Out-of-Hospital Cardiac Arrest (EROCA) Trial Planning Grant$348,750
R34 · FY2017 · HL
Electrochemical Generation of Nitric Oxide for Gas Phase Biomedical Applications$187,522
R21 · FY2017 · HD · contact PI
Bactericidal, Nonthrombogenic Intravascular Catheters$689,919
R01 · FY2016 · HL · contact PI
Extracorporeal CPR for Refractory Out-of-Hospital Cardiac Arrest (EROCA) Trial Planning Grant$348,750
R34 · FY2016 · HL
Electrochemical Generation of Nitric Oxide for Gas Phase Biomedical Applications$226,453
R21 · FY2016 · HD · contact PI
Bactericidal, Nonthrombogenic Intravascular Catheters$714,919
R01 · FY2015 · HL · contact PI
Combined Nitric Oxide Release and Argatroban for Thromboresistant Coatings$188,543
R21 · FY2014 · EB · contact PI
Pediatric Implantable Artificial Lung$484,382
R01 · FY2013 · HD · contact PI
Combined Nitric Oxide Release and Argatroban for Thromboresistant Coatings$233,250
R21 · FY2013 · EB · contact PI
Mini ECMO Life Support System$228,592
R41 · FY2013 · HD · contact PI
Pediatric Implantable Artificial Lung$527,981
R01 · FY2012 · HD · contact PI
Development of a Total Artificial Lung$997,603
R01 · FY2011 · HL · contact PI
Extracorporeal Circulation Without Anticoagulation$557,534
R01 · FY2011 · HD · contact PI
Development of a Total Artificial Lung$982,500
R01 · FY2010 · HL · contact PI
Extracorporeal Circulation Without Anticoagulation$581,838
R01 · FY2010 · HD · contact PI
Development of a Total Artificial Lung$55,215
R01 · FY2010 · HL · contact PI
Development of a Total Artificial Lung$1,080,201
R01 · FY2009 · HL · contact PI
Extracorporeal Circulation Without Anticoagulation$592,257
R01 · FY2009 · HD · contact PI
Development of a Total Artificial Lung$21,717
R01 · FY2009 · HL · contact PI
Development of a Total Artificial Lung$964,147
R01 · FY2008 · HL · contact PI
Extracorporeal Circulation Without Anticoagulation$590,614
R01 · FY2008 · HD · contact PI
Development of a Total Artificial Lung$26,540
R01 · FY2008 · HL · contact PI
Development of a Total Artificial Lung$821,764
R01 · FY2007 · HL · contact PI
Development of a Total Artificial Lung$1,222,026
R01 · FY2006 · HL · contact PI
Extracorporeal Circulation Without Anticoagulation$550,438
R01 · FY2006 · HD · contact PI
Development of a Total Artificial Lung$1,126,972
R01 · FY2005 · HL
Extracorporeal Circulation Without Anticoagulation$581,665
R01 · FY2005 · HD
Development of a Total Artificial Lung$978,673
R01 · FY2004 · HL
Extracorporeal Circulation Without Anticoagulation$591,126
R01 · FY2004 · HD
Development of a Total Artificial Lung$6,701
R01 · FY2004 · HL
Development of a Total Artificial Lung$873,049
R01 · FY2003 · HL
Development of a Total Artificial Lung$37,732
R01 · FY2003 · HL
Development of a Total Artificial Lung$884,809
R01 · FY2002 · HL
ECLS IN MULTIPLE ORGAN FAILURE$409,003
R01 · FY2002 · HD
ECLS IN MULTIPLE ORGAN FAILURE$394,315
R01 · FY2001 · HD
ECLS IN MULTIPLE ORGAN FAILURE$380,310
R01 · FY2000 · HD